RGENRepligen Corporation
176.58USD+0.12%Mkt Cap: 9.95B $P/E: 241.59

Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. The company's products include hollow fib…

Key Statistics

Company
Market Cap9.95B $
Enterprise Value10.06B $
Revenue (TTM)785.10M $
Gross Profit386.25M $
Net Income (TTM)48.89M $
Revenue/Share13.94 USD
Last Price176.58 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees2.0K
CountryUS
SectorHealthcare
IndustryMedical Instruments & Supplies
ISINUS7599161095
Valuation
P/E (Trailing)241.59
P/E (Forward)68.32
PEG2.21
EV/EBITDA69.78
EV/Revenue12.81
P/S12.96
P/B4.82
EPS (TTM)0.74
EPS (Forward)2.64
52W Range
100.9996% of range179.87
52W High179.87 USD
52W Low100.99 USD
Profitability
Gross Margin52.32%
Oper. Margin9.31%
EBITDA Margin18.35%
Profit Margin6.62%
ROE2.32%
ROA1.66%
Growth
Revenue Growth11.90%
Earnings Growth-65.90%
Cash Flow & Leverage
Operating CF117.42M $
CapEx (TTM)25.73M $
FCF Margin14.45%
FCF Yield1.14%
Net Debt-119.51M $
Net Debt/EBITDA-0.83
Balance Sheet
Debt/Equity0.33
Current Ratio9.05
Quick Ratio7.30
Book Value/Sh37.43 USD
Cash/Share14.36 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating1.5 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)185.70 USD
Upside (mean)+5.2%
Target Range145.00 USD220.00 USD
$145.00+5.2% to mean$220.00
# Analysts20
Ownership
Shares Out.56.44M
Float53.47M
Insiders5.24%
Institutions120.02%
Short Interest
Short Ratio5.1d
Short % Float10.90%
Short % Out.10.87%
Shares Short6.13M
Short (prev mo.)6.05M
Technical
SMA 50145.94 (+21.0%)
SMA 200140.45 (+25.7%)
Beta1.01
S&P 52W Chg18.16%
Avg Vol (30d)1.14M
Avg Vol (10d)951.69K
Technical Indicators
RSI (14)76.3
MACD8.5417
MACD Signal6.7400
MACD Hist.+1.8017
BB Upper180.73 USD
BB Middle153.20 USD
BB Lower125.67 USD
BB Width35.94%
ATR (14)6.995 USD
Vol Ratio (20d)1.45x